Zobrazeno 1 - 6
of 6
pro vyhledávání: '"M. J. Uprichard"'
Autor:
M. A. Barve, W. Fisher, Z. Yang, H. Patel, F. W. Nugent, E. C. Jurkowski, E. Meiri, Y. V. Oza, M. J. Uprichard, C. Cunningham
Publikováno v:
Journal of Clinical Oncology. 25:4616-4616
4616 Background: Talabostat is an oral small molecule inhibitor of fibroblast activation protein (FAP), a stromal enzyme with collagenase and dipeptidyl peptidase activity. Talabostat also upregulates cytokine and chemokine production, resulting in i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::59ea52a1e6fea311cc17b3b78d0b47b5
https://doi.org/10.1200/jco.2007.25.18_suppl.4616
https://doi.org/10.1200/jco.2007.25.18_suppl.4616
Autor:
J. Stephenson, Steven J. O'Day, G. Frenette, Anna C. Pavlick, Z. Yang, C. Cunningham, K. Khan, M. J. Uprichard, Ricardo J. Gonzalez, V. Vrhovac
Publikováno v:
Journal of Clinical Oncology. 24:8040-8040
8040 Background: Talabostat (TAL) is an oral inhibitor of dipeptidyl peptidases such as fibroblast activation protein found on the stroma of tumors, draining lymph nodes, and in melanomas. TAL up-regulates cytokines and chemokines, leading to specifi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::91e0289f3c9d265c041654faac1dcd73
https://doi.org/10.1200/jco.2006.24.18_suppl.8040
https://doi.org/10.1200/jco.2006.24.18_suppl.8040
Autor:
K. D. Khan, Camille N. Abboud, Kanti R. Rai, E. J. Haltom, P. Conkling, David D. Hurd, M. J. Uprichard, Jennifer R. Brown, Z. Yang, Susan O'Brien
Publikováno v:
Journal of Clinical Oncology. 24:6598-6598
6598 Background: Talabostat (TAL) is an orally administered small molecule inhibitor of dipeptidyl peptidases such as CD26 and fibroblast activation protein (FAP) in bone marrow, lymph nodes, and stroma of solid tumors, and TAL induces cytokine and c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::dea51f631c60d0680babbcfe7dc69787
https://doi.org/10.1200/jco.2006.24.18_suppl.6598
https://doi.org/10.1200/jco.2006.24.18_suppl.6598
Autor:
Robert N. Raju, R. Leonard, Casey Cunningham, S. Packer, Ravi Salgia, Donald A. Richards, J. Arseneau, L. Gregoire, M. J. Uprichard, E. Haltom
Publikováno v:
Journal of Clinical Oncology. 23:7120-7120
7120 Background: Talabostat (T) is an oral inhibitor of dipeptidyl peptidases such as fibroblast activation protein found on the stroma of tumors. Administration of T stimulates cytokine and chemok...
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b8d57335c94b3c63652e63936ab93f3f
https://doi.org/10.1200/jco.2005.23.16_suppl.7120
https://doi.org/10.1200/jco.2005.23.16_suppl.7120
Autor:
V. Vrhovac, Donald A. Richards, Stephen P. Anthony, J. Stephenson, M. J. Uprichard, C. Cunningham, Anna C. Pavlick, Steven J. O'Day, G. Frenette, P. A. Pacciucci
Publikováno v:
Journal of Clinical Oncology. 23:7563-7563
7563 Background: Talabostat (T) is an oral inhibitor of dipeptidyl peptidases including fibroblast activation protein found on the stroma of tumors and in melanomas. T stimulates cytokine and chemo...
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4aedeefc64baf3baeac491d2d415dff1
https://doi.org/10.1200/jco.2005.23.16_suppl.7563
https://doi.org/10.1200/jco.2005.23.16_suppl.7563
Autor:
De Matos, Raphaël, Vuilleumier, Jérémy, Mas, Christophe, Constant, Samuel, Staedler, Davide, Gerber-Lemaire, Sandrine
Publikováno v:
RSC Advances; 8/30/2019, Vol. 9 Issue 54, p31659-31669, 11p